tiprankstipranks
pc:allro

AllRock Bio

Therapeutics
AllRock Bio is a clinical-stage biotechnology company dedicated to developing innovative therapies for cardiopulmonary and fibrotic diseases. The company's lead candidate, ROC-101, is a first-in-class, oral pan-ROCK inhibitor designed to address the significant unmet need in treating pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (ILD-PH). With a focus on targeting the underlying mechanisms of these life-threatening conditions, AllRock Bio aims to provide disease-modifying treatments that go beyond symptom management.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$50M
Total Amount Raised$50M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$50M
Latest Funding Amount$50M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 16, 2025
Series A
$50.00M
―

Investors

Investor Name
Funding Round
Versant Ventures
Series A
Westlake BioPartners
Series A

Related News and Analysis

AllRock Bio Begins Phase 2a ROCSTAR Trial of Lead Pan-ROCK Inhibitor in Pulmonary Hypertension

AllRock Bio Begins Phase 2a ROCSTAR Trial of Lead Pan-ROCK Inhibitor in Pulmonary Hypertension

New updates have been reported about AllRock Bio. AllRock Bio, Inc. has initiated patient dosing in its Phase...
13h ago
ALLRO
Florida AG Targets OpenAI in Probe Over Alleged ChatGPT Role in Campus Shooting

Florida AG Targets OpenAI in Probe Over Alleged ChatGPT Role in Campus Shooting

New updates have been reported about OpenAI. Florida Attorney General James Uthmeier has opened an investigation into OpenAI...
1h ago
OPAIQ
Aledade’s Culture Wins National Recognition, Bolstering Its Value-Based Care Strategy

Aledade’s Culture Wins National Recognition, Bolstering Its Value-Based Care Strategy

New updates have been reported about Aledade. Aledade has secured a 2026 USA Today Top Workplaces award, spotlighting...
2h ago
ALEDE
Congruence Therapeutics Targets Investors at Needham Virtual Healthcare Conference

Congruence Therapeutics Targets Investors at Needham Virtual Healthcare Conference

New updates have been reported about Congruence Therapeutics. Congruence Therapeutics will seek to deepen its investor engagement at...
4h ago
CONGR
Tipalti Highlights SAP-Focused AP Automation and Navigator Partnership in Upcoming Webinar

Tipalti Highlights SAP-Focused AP Automation and Navigator Partnership in Upcoming Webinar

According to a recent LinkedIn post from Tipalti, the company is promoting a free 30-minute webinar on April...
6h ago
TIPAL
AmplifAI Highlights Strategic Alignment With Dataiku’s Enterprise AI Platform

AmplifAI Highlights Strategic Alignment With Dataiku’s Enterprise AI Platform

A LinkedIn post from AmplifAI discusses Dataiku’s newly launched “Platform for AI Success” and its relevance for enterprise...
6h ago
AMPLI
Axtria Highlights Role in Analytics-Focused Pharma Conference Attendance

Axtria Highlights Role in Analytics-Focused Pharma Conference Attendance

According to a recent LinkedIn post from Axtria, the company plans to participate in the Pharmaceutical Management Science...
6h ago
AXTRI
Celonis Enhances Process Platform With New Value Tracking and AI Features

Celonis Enhances Process Platform With New Value Tracking and AI Features

A LinkedIn post from Celonis highlights new product updates aimed at tightening the link between process visibility, artificial...
6h ago
CLONS
Media Coverage Underscores Growing Focus on Sepsis Diagnostics and Risk Assessment

Media Coverage Underscores Growing Focus on Sepsis Diagnostics and Risk Assessment

A LinkedIn post from Cytovale highlights media coverage examining the difficulty of recognizing sepsis in emergency departments. The...
6h ago
CYTOV
AppZen Highlights AI-Driven AP Automation Aimed at Faster Deployment

AppZen Highlights AI-Driven AP Automation Aimed at Faster Deployment

According to a recent LinkedIn post from AppZen, the company is highlighting its AP Inbox Service Center as...
6h ago
APPZE